In January 2026, Sunlight.com surveyed 2,000 overweight Americans to assess their awareness of and interest in GLP-1 medications in pill form
In sports, cerebrolysin used to enhance mental function and defog the brain, although there is no good evidence that it has any effect in healthy individuals
education, insulin regimen, use of adjuvant therapies, access to newer technologies, need for psychosocial support to address the profound psychological impact of the diagnosis of diabetes and concurrent disease screening may all depend on the diagnosis an individual receives
Companies with membership fees, like Hone, list much lower prices for their medications, but those prices exist on top of membership fees
The global GLP-1 receptor agonist market size is valued at USD 53.5 billion in 2024 and is expected to grow to USD 62.86 billion by 2025